Cue biopharma appoints industry veteran lucinda warren as chief business officer

Boston, sept. 09, 2024 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific t cells, today announced the appointment of industry veteran lucinda warren as chief business officer (cbo).
CUE Ratings Summary
CUE Quant Ranking